title: IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
authors.forename: Weldon
authors.initials: W
authors.lastname: Chiu
authors.forename: Humphrey
authors.initials: H
authors.lastname: Pullon
authors.forename: See-Tarn
authors.initials: ST
authors.lastname: Woon
authors.forename: Paul
authors.initials: P
authors.lastname: Oei
authors.forename: Roy
authors.initials: R
authors.lastname: The
authors.forename: Rohan
authors.initials: R
authors.lastname: Ameratunga
mesh_terms: D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001854:Bone Marrow Cells / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007070:Immunoglobulin A / Q000097:blood*; D007073:Immunoglobulin E / Q000097:blood*; D007145:Immunoglobulin kappa-Chains / Q000097:blood*; D007952:Leukemia, Plasma Cell / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D009194:Myeloma Proteins / Q000032:analysis*; D016609:Neoplasms, Second Primary; D011241:Prednisone / Q000627:therapeutic use; D000077211:Zoledronic Acid
chemical_list: D018906:Antineoplastic Agents, Alkylating; D004164:Diphosphonates; D007093:Imidazoles; D007070:Immunoglobulin A; D007145:Immunoglobulin kappa-Chains; D009194:Myeloma Proteins; D007073:Immunoglobulin E; D000077211:Zoledronic Acid; D008558:Melphalan; D011241:Prednisone